The Orthopaedic Trauma Association is proud to provide this syllabus of lectures, written and edited by the membership, to support comprehensive orthopaedic trauma resident education. These presentations were created for use by educators and are supplied in a fashion that specifically allows for modification. The OTA respectfully requests that proper credit be given to the original author as well as the OTA when the talks are presented, even in modified form. These talks represent a combination of the literature, as cited, and current practices, as reported by member-authors.
Version IV is in the process of being updated in its entirety. In the interim certain presentations have been recently updated, including a newly published Blast Injuries lecture.
The OTA is committed to maintaining and updating the content of these lectures. Comments and suggestions for revisions are encouraged and should be sent to: firstname.lastname@example.org
- Disaster Preparedness and Response
- Upper Extremity
- Lower Extremity
- Pelvis and Acetabulum
- Version IV Project Directors:
- Phase 1: Kenneth J. Koval, MD
- Phase 2 and Phase 3: Lisa Cannada, MD
- Version IV Section Editors, Phase 1:
- General: Lisa Cannada, MD; Erik Kubiak, MD
- Lower Extremity: Cory A. Collinge, MD
- Pediatrics: Kyle J. Jeray, MD
- Pelvis & Acetabulum: Erik Kubiak, MD
- Upper Extremity: John T. Capo, MD
The material presented in this program has been made available by the Orthopaedic Trauma Association (OTA) for educational purposes only. This material is not intended to represent the only, nor necessarily best, methods or procedures appropriate for the medical situations discussed, but rather is intended to present an approach, view, statement or opinion of the author(s) or editor(s) which may be helpful to others who face similar situations. All drugs and medical devices used in the United States are administered in accordance with Food and Drug Administration (FDA) regulations. These regulations vary depending on the risks associated with the drug or medical device, the similarity of the drug or medical device to products already on the market, and the quality and scope of clinical data available. Some drugs and medical devices demonstrated in OTA courses or described in OTA print or electronic publications have FDA clearance for use for specific purposes or for use only in restricted research settings. It is the responsibility of the physician to determine the FDA status of each drug or device he or she wishes to use in clinical practice, and to use the products with the appropriate patient consent and compliance with applicable law. Furthermore, any statements about commercial products are solely the opinion(s) of the author(s) and do not represent an OTA endorsement or evaluation of these products. These statements may not be used in advertising or for any commercial purpose. The material contained in this program was submitted as previously unpublished material, except in instances in which credit has been given to the source from which some illustrative material was derived. Materials appearing in this program prepared by individuals as part of their official duties as U.S. Government employees are not covered by the above-mentioned copyright. Copyright © 2012 by the Orthopaedic Trauma Association. All rights reserved.